Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lennox-Gastaut syndrome

J W Wheless1, J E Constantinou

  • 1Department of Neurology, University of Texas-Houston, 77225-0708, USA.

Pediatric Neurology
|December 9, 1997
PubMed
Summary

Lennox-Gastaut syndrome (LGS) is a severe childhood epilepsy. New medications and non-pharmacologic treatments offer improved seizure control and potential to lessen its impact.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortical Activation Through Passive-Motion Functional MRI.

AJNR. American journal of neuroradiology·2015
Same author

Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.

Neurology·2004
Same author

MEG localization of language-specific cortex utilizing MR-FOCUSS.

Neurology·2004
Same author

Does magnetoencephalography add to scalp video-EEG as a diagnostic tool in epilepsy surgery?

Neurology·2004
Same author

Patient with bilateral periventricular nodular heterotopia and polymicrogyria with apparently balanced reciprocal translocation t(1;6)(p12;p12.2) that interrupts the mannosidase alpha, class 1A, and glutathione S-transferase A2 genes.

Journal of medical genetics·2003
Same author

Periventricular heterotopia associated with chromosome 5p anomalies.

Neurology·2003

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Neuroscience

Background:

  • Lennox-Gastaut syndrome (LGS) is a severe, intractable childhood epilepsy.
  • It is characterized by epileptic encephalopathy and a poor long-term prognosis, including intellectual disability and dependence.
  • Despite being recognized for 30 years, LGS pathogenesis remains incompletely understood.

Purpose of the Study:

  • To review current understanding and management of Lennox-Gastaut syndrome.
  • To highlight recent advances in LGS therapies.
  • To emphasize the need for multidisciplinary care and early intervention.

Main Methods:

  • Review of current literature on Lennox-Gastaut syndrome.
  • Analysis of recent therapeutic advancements, including pharmacologic and non-pharmacologic options.
  • Discussion of the natural history and management strategies for LGS.

Main Results:

  • Several new antiepileptic drugs with documented efficacy are now available for LGS.
  • Effective non-pharmacologic treatments have also emerged.
  • These advancements offer hope for improved seizure control and reduced epileptic encephalopathy.

Conclusions:

  • LGS requires comprehensive, multidisciplinary assessment and treatment.
  • Vigorous intervention to minimize seizures is crucial for maximizing patient potential.
  • Pediatric neurologists must be aware of proven treatments, including new antiepileptic drugs, to develop individualized care plans.

Related Experiment Videos